Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 11701 - 11725 of 12566 in total
Sepofarsen is under investigation in clinical trial NCT03913143 (A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)).
Investigational
Matched Description: … , Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)). ... Sepofarsen is under investigation in clinical trial NCT03913143 (A Study to Evaluate Efficacy, Safety …
Nadecnemab is under investigation in clinical trial NCT03956550 (A Study to Examine the Efficacy and Safety of REGN5069 in Patients With Pain Due to Osteoarthritis of the Knee).
Investigational
Matched Description: … Safety of REGN5069 in Patients With Pain Due to Osteoarthritis of the Knee). ... Nadecnemab is under investigation in clinical trial NCT03956550 (A Study to Examine the Efficacy and …
Bopindolol (INN) is an ester prodrug for the beta blocker pindolol.
Experimental
Razuprotafib, also known as AKB-9778, is a small-molecule inhibitor restoring Tie2 activation by inhibiting VE-PTP.[L27171,L27176] In investigations against diabetes and COVID-19, razuprotafib is self-administered by patients through subcutaneous injection.
Investigational
Matched Description: … [L27171,L27176] In investigations against diabetes and COVID-19, razuprotafib is self-administered by …
Topsalysin is being developed for the treatment of localized prostate cancer and also benign prostatic hyperplasia. Topsalysin is delivered locally to the prostate under ultrasound guidance.
Investigational
Briakinumab is a human anti-IL-12 monoclonal antibody being developed for the treatment of a number of T-cell driven autoimmune diseases. It targets and neutralize interleukin-12 and interleukin-23, two proteins associated with inflammation, such as pro-inflammatory interleukins or tumor necrosis factor- alpha. Briakinumab represents a novel approach to treating psoriasis, Multiple...
Investigational
Matched Description: … As of 2011 drug development for psoriasis has been discontinued in the U.S. and Europe. …
Investigational
AVI-7537 is an antisense molecule that binds to the Ebola virus mRNA to prevent the viral replication. AVI-7537 is under investigation in clinical trial NCT01593072 (A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers).
Investigational
Matched Description: … Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers). ... [L46207] AVI-7537 is under investigation in clinical trial NCT01593072 (A Study to Assess the Safety, …
Gemogenovatucel-T is a bi-shRNA furin/Granulocyte Macrophage Colony Stimulating Factor (GMCSF) Augmented autologous tumour cell vaccine. Furin is a convertase involved in the activation of TGFβ-1 and TGFβ-2. Gemogenovatucel-T is being investigated in the treatment of various cancers.
Investigational
Matched Description: … Furin is a convertase involved in the activation of TGFβ-1 and TGFβ-2. ... [A255163] Gemogenovatucel-T is being investigated in the treatment of various cancers. …
Beraprost is a synthetic analogue of prostacyclin, under clinical trials for the treatment of pulmonary hypertension. It is also being studied for use in avoiding reperfusion injury.
Investigational
Matched Description: … It is also being studied for use in avoiding reperfusion injury. …
Fitusiran is under investigation in clinical trial NCT02554773 (An Open-label Extension Study of an Investigational Drug, ALN-AT3SC, in Patients With Moderate or Severe Hemophilia A or B).
Investigational
Matched Description: … Drug, ALN-AT3SC, in Patients With Moderate or Severe Hemophilia A or B). ... Fitusiran is under investigation in clinical trial NCT02554773 (An Open-label Extension Study of an Investigational …
2'-Fucosyllactose is under investigation in clinical trial NCT03847467 (Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-tnf Therapy).
Investigational
Matched Description: … 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-tnf Therapy). ... 2'-Fucosyllactose is under investigation in clinical trial NCT03847467 (Pilot and Feasibility Study of …
NRX-1074 has been used in trials studying the treatment of Schizophrenia.
Investigational
Matched Description: … NRX-1074 has been used in trials studying the treatment of Schizophrenia. …
Lampalizumab has been used in trials studying the treatment of Geographic Atrophy.
Investigational
Matched Description: … Lampalizumab has been used in trials studying the treatment of Geographic Atrophy. …
Placulumab has been used in trials studying the treatment of Rheumatoid Arthritis.
Investigational
Matched Description: … Placulumab has been used in trials studying the treatment of Rheumatoid Arthritis. …
Vanillyl alcohol has been used in trials studying the treatment of Smoking.
Investigational
Matched Description: … Vanillyl alcohol has been used in trials studying the treatment of Smoking. …
Vatelizumab has been used in trials studying the treatment of Ulcerative Colitis.
Investigational
Matched Description: … Vatelizumab has been used in trials studying the treatment of Ulcerative Colitis. …
Selepressin has been used in trials studying the treatment of Septic Shock.
Investigational
Matched Description: … Selepressin has been used in trials studying the treatment of Septic Shock. …
FK614 has been used in trials studying the treatment of Diabetes Mellitus.
Investigational
Matched Description: … FK614 has been used in trials studying the treatment of Diabetes Mellitus. …
Balugrastim has been used in trials studying the treatment of Solid Tumors.
Investigational
Matched Description: … Balugrastim has been used in trials studying the treatment of Solid Tumors. …
Solamargine has been used in trials studying the treatment of Actinic Keratosis.
Investigational
Matched Description: … Solamargine has been used in trials studying the treatment of Actinic Keratosis. …
NM-3 has been used in trials studying the treatment of Neoplasms.
Investigational
Matched Description: … NM-3 has been used in trials studying the treatment of Neoplasms. …
Ly2300559 has been used in trials studying the prevention of Migraine Headache.
Investigational
Matched Description: … Ly2300559 has been used in trials studying the prevention of Migraine Headache. …
Tregalizumab has been used in trials studying the treatment of Rheumatoid Arthritis.
Investigational
Matched Description: … Tregalizumab has been used in trials studying the treatment of Rheumatoid Arthritis. …
BIIB115 is an investigational antisense oligonucleotide in development for spinal muscular atrophy.
Investigational
Matched Description: … BIIB115 is an investigational antisense oligonucleotide in development for spinal muscular atrophy. …
Displaying drugs 11701 - 11725 of 12566 in total